Zydus Lifesciences Sees Profitable Growth in Q1 FY2026
Zydus Lifesciences reported a 3% year-on-year increase in net profit to Rs 1,467 crore for the first quarter of 2025. Operating revenue rose to Rs 6,574 crore. The company attributes its performance to disciplined execution and is optimistic about future growth and innovations.
- Country:
- India
Zydus Lifesciences has announced a 3% increase in its consolidated net profit for the first quarter ending June 30, 2025, achieving Rs 1,467 crore compared to Rs 1,420 crore in the previous fiscal period.
The pharmaceutical giant reported increased revenue from operations of Rs 6,574 crore, up from Rs 6,207 crore in the same quarter last year, highlighting steady financial growth.
Managing Director Sharvil Patel attributed this performance to disciplined execution across key business areas and expressed optimism for potential growth through future innovations. Zydus Lifesciences saw a slight rise in its stock, closing up 0.27% at Rs 958.05 on BSE.
(With inputs from agencies.)
Advertisement
ALSO READ
Newcastle United: Alexander Isak's Absence and Team Resilience Amid Transfer Rumors
Countdown to NISAR: Pioneering Earth Observation Sets July Launch
Alembic Pharmaceuticals Secures USFDA Nod for Carbamazepine Tablets
Torrent Pharmaceuticals: Riding the Wave of Revenue Growth
Sikkim MP Advocates for Vernacular Language Inclusion in CBSE Curriculum
Google News